Methylation and other new concepts for the origin of hepatocellular carcinoma;Entstehung hepatozellulärer karzinome: Methylierung und andere neue konzepte

Pathologe

Volumn 27, Issue 4, 2006, Pages 284-288

  Tannapfel, A ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

DNA methylation; Gene changes; Hepatocellular carcinoma (HCC); Tumorigenesis

Indexed keywords

BIOLOGICAL MARKER; CARBON; DNA METHYLTRANSFERASE; HYDROGEN; METHYL GROUP;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHROMOSOME 3P; DNA METHYLATION; DNA MODIFICATION; FLUORESCENCE; GENE EXPRESSION REGULATION; HUMAN; LIVER CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; REAL TIME POLYMERASE CHAIN REACTION;

CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 33745726382     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-006-0837-y     Document Type: Article

References (16)

1. Agathanggelou A, Dallol A, Zochbauer-Muller S et al. (2003) Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene 22: 1580-1588
2. Baylin SB (2005) DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2 Suppl 1(S1): S4-S11
3. Christensen C, Ambartsumian N, Gilestro G et al. (2005) Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis. Cancer Res 65: 6167-6177
4. De Zhu J (2005) The altered DNA methylation pattern and its implications in liver cancer. Cell Res 15: 272-280
5. Galm O, Herman JG (2005) Methylation-specific polymerase chain reaction. Methods Mol Med 113: 279-291
6. Lee JO, Kwun HJ, Jung JK et al. (2005) Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 24: 6617-6625
7. Lyko F, Brown R (2005) DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst 97: 1498-1506
8. Martin C, Zhang Y (2005) The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6: 838-849
9. Tada M, Yokosuka O, Fukai K et al. (2005) Hypermethylation of NAD(P)H: quinone oxidoreductase 1 (NQO1) gene in human hepatocellular carcinoma. J Hepatol 42: 511-519
10. Tannapfel A, Wittekind C (2001) Preneoplasia of the liver. Definition - differential diagnosis - clinical consequences. Pathologe 22: 399-406
11. Tannapfel A, Wittekind C (2002) Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis. Virchows Arch 440: 345-352
12. Tannapfel A, Busse C, Weinans L et al. (2001) INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene 20: 7104-7109
13. Tannapfel A, Anhalt K, Häusermann P et al. (2003) Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J Pathol 201: 238-249
14. Tischoff I, Markwarth A, Witzigmann H et al. (2005) Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. Int J Cancer 115: 684-689
15. Weber A, Hengge UR, Bardenheuer W et al. (2005) SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene 24: 6699-6708
16. Yu MW, Yeh SH, Chen PJ et al. (2005) Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 97: 265-272